In September 29, 1994, the UP Board of Regents created the Institute of Molecular Biology and Biotechnology at the National Institutes of Health with its aim of promoting and implementing research focusing on the prevention, early diagnosis, and treatment of infectious diseases that pose as major threats and primary causes of mortality in the Philippines.

In February 2, 1995, then president Fidel Ramos issued Proclamation no. 526 constituting the various biotechnology institutes within the University of the Philippines System as the network of the national institutes of biotechnology, and designating said network as a National Center of Excellence in Molecular Biology and Biotechnology.

In September 3, 1998, then University of the Philippines President Emil Q. Javier issued

an executive order 98-1 providing for the organizational structure and staffing pattern of the network of the national institutes of molecular biology and biotechnology (BIOTECH).

With strong support from the University of the Philippines and the Department of Science and Technology, today Biotech-Manila is re-invigorating its efforts in advancing medical and health-related biotechnology researches focusing on the top 10 causes of morbidity and mortality in the country.

Biotech-manila aims to transform basic science into translational and applied science that could be readily utilized to give solutions to the most pressing problems that we encounter everyday by forging partnerships with health institutions and bio-industries, local and international.

Ongoing Projects

3-D Targets: The UK Philippines Dengue Diagnostics and Drug Targets Research Consortium

HIV Drug Resistance Surveillance Library and Development of Molecular Diagnostics for Drug-Resistance Detection- Part 1: Surveillance of Mutations for Acquired Drug Resistance

Dengue: Climate, Evolution and Transmission

Improving the Molecular Diagnostics of Drug Resistant Tuberculosis

Responding to the Philippine HIV epidemic: an HIV drug resistance surveillance library and development of molecular diagnostics for drug-resistance detection:Part 2: Analysis and prevalence of pre-treatment drug resistance



The UPM - IBBC is organizing a Training Program for Laboratory Biosafety and Biosecurity Officers to commence in the second quarter of 2016. The main objective of the program is to develop a pool of local trainers who will undertake advocacy and continuing education on laboratory biosafety and biosecurity. At the end of the training, the trainers are expected to be competent in the following areas:

*Biosafety and biosecurity risk assessment *Laboratory vivarium Biosafety and Biosecurity *Biocontainment practices and procedures *Biocontainment facilities *Use of safety equipment *Incident response procedures *Infectious substance transport *Biosafety program management *Management of transgenic materials *Regulatory framework of transgenic materials

The training will entail at least ten modules, each of which with duration of two weeks, scheduled on July 18-29, 2016; September 18- October 1, 2016; and November 20- December 3, 2016.

For more information please click the download link: Download